| Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant … A Bashey, MJ Zhang, SR McCurdy, A St. Martin, T Argall, C Anasetti, ... Journal of Clinical Oncology 35 (26), 3002-3009, 2017 | 281 | 2017 |
| Autologous transplantation in follicular lymphoma with early therapy failure: a National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis C Casulo, JW Friedberg, KW Ahn, C Flowers, A DiGilio, SM Smith, ... Biology of blood and marrow transplantation 24 (6), 1163-1171, 2018 | 151 | 2018 |
| Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide SR McCurdy, MJ Zhang, A St. Martin, MM Al Malki, A Bashey, S Gaballa, ... Blood advances 2 (3), 299-307, 2018 | 87 | 2018 |
| Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome SO Ciurea, MV Shah, RM Saliba, S Gaballa, P Kongtim, G Rondon, ... Biology of blood and marrow transplantation 24 (6), 1232-1236, 2018 | 81 | 2018 |
| Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched … S Gaballa, I Ge, R El Fakih, JE Brammer, P Kongtim, C Tomuleasa, ... Cancer 122 (21), 3316-3326, 2016 | 81 | 2016 |
| Treatment with hypomethylating agents before allogeneic stem cell transplant improves progression-free survival for patients with chronic myelomonocytic leukemia P Kongtim, U Popat, A Jimenez, S Gaballa, R El Fakih, G Rondon, J Chen, ... Biology of Blood and Marrow Transplantation 22 (1), 47-53, 2016 | 75 | 2016 |
| NCCN guidelines® insights: Chronic Lymphocytic leukemia/small Lymphocytic lymphoma, version 3.2022: Featured updates to the NCCN Guidelines WG Wierda, J Brown, JS Abramson, F Awan, SF Bilgrami, G Bociek, ... Journal of the National Comprehensive Cancer Network 20 (6), 622-634, 2022 | 59 | 2022 |
| Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas J Svoboda, SM Bair, DJ Landsburg, SD Nasta, SJ Nagle, SK Barta, ... Haematologica 106 (6), 1705, 2021 | 56 | 2021 |
| Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation S Gaballa, R Saliba, B Oran, JE Brammer, J Chen, G Rondon, AM Alousi, ... American journal of hematology 92 (4), 331-337, 2017 | 52 | 2017 |
| A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease D Grosso, S Gaballa, O Alpdogan, M Carabasi, J Filicko-O’Hara, ... Biology of Blood and Marrow Transplantation 21 (4), 646-652, 2015 | 48 | 2015 |
| Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes JE Brammer, RM Saliba, JL Jorgensen, C Ledesma, S Gaballa, M Poon, ... Bone marrow transplantation 52 (1), 20-27, 2017 | 47 | 2017 |
| FLT3 inhibitors for treating acute myeloid leukemia M Hassanein, MH Almahayni, SO Ahmed, S Gaballa, R El Fakih Clinical Lymphoma Myeloma and Leukemia 16 (10), 543-549, 2016 | 46 | 2016 |
| Outcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioning JE Brammer, I Khouri, S Gaballa, P Anderlini, C Tomuleasa, S Ahmed, ... Biology of Blood and Marrow Transplantation 22 (3), 493-498, 2016 | 44 | 2016 |
| Outcome of patients with multiple myeloma and CKS1B gene amplification after autologous hematopoietic stem cell transplantation F Bock, G Lu, SA Srour, S Gaballa, HY Lin, V Baladandayuthapani, ... Biology of Blood and Marrow Transplantation 22 (12), 2159-2164, 2016 | 36 | 2016 |
| A two-step haploidentical versus a two-step matched related allogeneic myeloablative peripheral blood stem cell transplantation S Gaballa, N Palmisiano, O Alpdogan, M Carabasi, J Filicko-O'Hara, ... Biology of Blood and Marrow Transplantation 22 (1), 141-148, 2016 | 34 | 2016 |
| Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration DM Stephens, K Boucher, E Kander, SA Parikh, EM Parry, M Shadman, ... Haematologica 106 (11), 2845, 2021 | 27 | 2021 |
| Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant S Gaballa, RM Saliba, S Srour, G Lu, JE Brammer, N Shah, Q Bashir, ... American journal of hematology 91 (10), E442-E447, 2016 | 25 | 2016 |
| Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization D Grosso, E Johnson, B Colombe, O Alpdogan, M Carabasi, ... Bone marrow transplantation 52 (4), 615-619, 2017 | 21 | 2017 |
| An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma JP Alderuccio, L Arcaini, MP Watkins, AW Beaven, G Shouse, N Epperla, ... Blood advances 6 (7), 2035-2044, 2022 | 19 | 2022 |
| Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma R Baz, S Fanning, L Kunkel, S Gaballa, MA Karam, J Reed, M Kelly, ... Leukemia & lymphoma 48 (12), 2338-2344, 2007 | 17 | 2007 |
